Cracking the Code on Generative AI: From Hype to Impact
Available On Demand
Watched our AIML 101 webinar and ready to learn more? Trinity Life Sciences is excited to continue the conversation with our next webinar, which will dive deeper into how pharma companies can move beyond the hype to unlock the value of Generative AI (GenAI).
Join Trinity experts, Steve Laux, VP of Commercial Insights & Advanced Analytics, Nabha Subramanya, VP of Data Science and Patrick Waring, Director of New Products & Strategy, as they sift through all the noise surrounding GenAI and share real-life use cases and practical actions that you should be doing now to drive impact for your organization.
AIML is here. Be ready with Trinity.
Key Webinar Topics
- Examine the current landscape of GenAI in the pharma industry
- Explore real-life, practical use cases of GenAI in pharma, with a focus on what’s working and what’s not
- Address the challenges of implementing GenAI, such as the rapidly changing tech stack
- Prioritize use cases based on their potential value for your organization
- Learn about Trinity’s framework for evaluating and implementing GenAI